BCBSKS Update – The Following Medical Policies Have Been Published to the BCBSKS Website.

 

• BRCA1 and BRCA2 Testing
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies
• Eteplirsen (Exondys 51) for Duchenne Muscular Dystrophy
• Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
• Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
• Noninvasive Techniques for the Evaluation and Monitoring of Patients with Chronic Liver Disease
• Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease

Source: https://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies.shtml